Story · Medicine & Biotech

Broad-Based Genomic Testing Improves Lifespan in Lung Cancer

1 outlet · first reported by Inside Precision Medicine 8h ago

Coverage, in order

  1. 8h ago
    Inside Precision Medicine indie
    Broad-Based Genomic Testing Improves Lifespan in Lung Cancer

    Comprehensive genomic sequencing of lung cancer tumors before first-line treatment could help patients with advanced disease live longer than more limited biomarker sampling, research suggests. The study, in JNCCN—Journal of the National Comprehensive Cancer Network (NCCN), highlights the benefits…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.